A Gleason score is a grading system that tells you how aggressive prostate cancer cells look under a microscope. Scores range from 6 (the lowest grade of cancer) to 10 (the most aggressive), and the number plays a major role in shaping your treatment plan and outlook. If you’ve just received a pathology report after a prostate biopsy, understanding this score is one of the most important steps in making sense of your diagnosis.
How the Score Is Calculated
After a prostate biopsy, a pathologist examines thin slices of tissue under a microscope. A typical biopsy collects 12 to 14 tissue samples, called cores, from different areas of the prostate. The pathologist looks at the cancer cells in each core and assigns them a pattern number from 1 to 5 based on how abnormal the cells appear. In practice, patterns 1 and 2 are no longer used in modern grading, so the lowest pattern you’ll see on a report is 3.
The final Gleason score is the sum of two pattern numbers. The first number represents the primary pattern, which is the pattern that makes up more than 50% of the cancer in the sample. The second number is the secondary pattern, the next most common appearance. So a score written as 3+4=7 means most of the cancer looks like pattern 3 (less abnormal), with a smaller portion looking like pattern 4 (more abnormal).
If the pathologist sees only one pattern throughout the sample, that number is doubled. A biopsy showing nothing but pattern 3, for example, would be scored 3+3=6.
Why the Order of the Numbers Matters
Two people can both receive a Gleason score of 7, but their cancers may behave quite differently. A score of 3+4=7 means the majority of the cancer is made up of well-formed glandular structures with a smaller component of more disorganized cells. A score of 4+3=7 flips that: most of the cancer consists of poorly formed or fused glands, with only a smaller portion of well-formed tissue. The 4+3 combination carries a higher risk of the cancer growing and spreading, even though the total is the same.
This distinction matters enough that the modern grading system splits these into entirely separate risk categories.
Grade Groups: The Updated System
Because the traditional Gleason score can be confusing, especially when the same total number means different things, doctors now also use a newer classification called Grade Groups. These run from 1 to 5 and map directly to Gleason scores:
- Grade Group 1 (Gleason score 6): Low risk. Only well-formed, individual glands are present.
- Grade Group 2 (Gleason score 3+4=7): Intermediate risk. Mostly well-formed glands with some poorly formed areas.
- Grade Group 3 (Gleason score 4+3=7): Intermediate risk, but higher than Group 2. Mostly poorly formed glands with some well-formed areas.
- Grade Group 4 (Gleason score 8): High risk. Entirely poorly formed glands, or a mix of very abnormal patterns.
- Grade Group 5 (Gleason scores 9 and 10): High risk. Cells that have largely lost any recognizable gland structure, sometimes with areas of dead tissue.
You may see both systems on your pathology report. Grade Groups make it easier to understand where your cancer falls on the risk spectrum, since a “Group 1 out of 5” feels more intuitive than a “6 out of 10” that is actually the lowest possible score.
What a Gleason 6 Really Means
Getting a Gleason 6 diagnosis can feel alarming because 6 out of 10 sounds like a mid-range score. In reality, 6 is the lowest grade of prostate cancer that gets diagnosed. Patterns 1 and 2 are essentially never assigned on modern biopsies, so there is no Gleason score of 2, 3, 4, or 5 in current practice. A Gleason 6 cancer is made up entirely of well-formed glands and grows slowly.
For this reason, the American Urological Association recommends active surveillance as the preferred approach for low-risk prostate cancer. Active surveillance means your cancer is monitored over time with periodic PSA blood tests, imaging such as MRI, and repeat biopsies rather than jumping straight to surgery or radiation. The goal is to preserve your quality of life by avoiding or delaying treatment for a cancer that is unlikely to cause harm, while keeping close enough watch that treatment can begin if the cancer shows signs of becoming more aggressive.
During active surveillance, a rising PSA level doesn’t automatically mean the cancer is progressing. Temporary PSA spikes are common, so your doctor will typically recheck the level before drawing conclusions. Sustained PSA increases, changes found on a physical exam, or findings on a new MRI would prompt a repeat biopsy to check whether the cancer’s grade has changed.
Higher Scores and What They Suggest
Gleason scores of 7 and above indicate cancer cells that look increasingly abnormal and are more likely to grow quickly or spread beyond the prostate. A Gleason 7 (particularly 4+3) generally prompts a conversation about active treatment options such as surgery or radiation, though some 3+4 cases may still be candidates for close monitoring depending on other factors like PSA level, the number of biopsy cores affected, and overall health.
Scores of 8 through 10 represent high-grade cancer. These cells have lost most or all of the organized gland structure that normal prostate tissue has. Treatment for high-grade cancers is typically more aggressive, and doctors often combine approaches to reduce the chance of the cancer returning or spreading.
Other Details on Your Pathology Report
The Gleason score is the centerpiece of a prostate biopsy report, but you’ll likely see other terms alongside it. One common finding is perineural invasion, which means cancer cells were seen growing around or along a nerve fiber within the prostate. This doesn’t change your Gleason score, but your doctor factors it into the overall picture when planning next steps.
Your report will also note how many of the biopsy cores contained cancer and what percentage of each core is affected. A single core with a small amount of Gleason 6 cancer tells a very different story than 10 out of 12 cores heavily involved with Gleason 8. These details, combined with your Gleason score or Grade Group, PSA level, and imaging results, form the full risk profile that guides treatment decisions.
When Biopsy and Surgery Scores Differ
It’s worth knowing that the Gleason score from a needle biopsy and the score from a surgically removed prostate don’t always match. Biopsies sample small slivers of tissue, so they can miss areas of higher-grade cancer. In needle biopsy specimens, if the pathologist sees more than two patterns, the scoring rule changes slightly: the primary pattern is combined with the worst (highest) pattern found, not necessarily the second most common one. This approach helps ensure the most aggressive component isn’t overlooked.
In surgical specimens examined after the prostate is removed, pathologists sometimes identify a tertiary pattern, a small third component of higher-grade cancer. Research published in the Journal of Urology found that the presence of a tertiary pattern independently predicted cancer recurrence, with the cancer behaving as though it were one full Gleason score category higher. In the case of 4+3=7 with a tertiary high-grade component, the cancer’s recurrence risk matched that of Gleason 8 tumors. This is one reason surgeons and oncologists sometimes adjust their follow-up plans after reviewing the final surgical pathology.